Organogenesis Holdings Inc. (ORGO) stock
ORGONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$0.85+0.04 (+5.13%)
Close on Nov 18, 2026Market cap $109.79MP/E –Yield –
Organogenesis total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Organogenesis's total debt was $49.63M at Dec 31, 2019. For fiscal 2019 it was $49.63M, up 294.6% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $49.63M | +294.6% |
| FY2018 | Dec 31, 2018 | $12.58M | -15.1% |
| FY2017 | Dec 31, 2017 | $14.82M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2019 | Dec 31, 2019 | $49.63M | +235.0% |
| Q2 FY2019 | Jun 30, 2019 | $39.66M | – |
| Q1 FY2019 | Mar 31, 2019 | $39.64M | – |
| Q4 FY2018 | Dec 31, 2018 | $12.58M | – |
| Q4 FY2017 | Dec 31, 2017 | $14.82M | – |
See a number that looks wrong?